Validation of Pre-/Post-TACE-Predict Models among Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization

SIMPLE SUMMARY: Transarterial chemoembolization (TACE) is used to treat patients with intermediate stage hepatocellular carcinoma (HCC). However, models to accurately predict survival are lacking. The aim of our retrospective study was to attempt to validate the prognostic performance of the newly p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, David Sooik, Kim, Beom Kyung, Lee, Jae Seung, Lee, Hye Won, Park, Jun Yong, Kim, Do Young, Ahn, Sang Hoon, Kim, Seung Up
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750487/
https://www.ncbi.nlm.nih.gov/pubmed/35008231
http://dx.doi.org/10.3390/cancers14010067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750487/
https://www.ncbi.nlm.nih.gov/pubmed/35008231
http://dx.doi.org/10.3390/cancers14010067

Ejemplares similares